1. Bauer, Jens, Köhler, Natalie, Maringer, Yacine, Hailfinger, Stephan, Walz, Juliane S. 2022. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma. In Nature communications, 13, 6401. doi:10.1038/s41467-022-33746-3. https://pubmed.ncbi.nlm.nih.gov/36302754/
2. Kirk, Allison M, Crawford, Jeremy Chase, Chou, Ching-Heng, Strome, Scott E, Thomas, Paul G. . DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma. In Cell reports. Medicine, 5, 101469. doi:10.1016/j.xcrm.2024.101469. https://pubmed.ncbi.nlm.nih.gov/38508137/
3. Katoh, Masaru. . GIPC gene family (Review). In International journal of molecular medicine, 9, 585-9. doi:. https://pubmed.ncbi.nlm.nih.gov/12011974/
4. Gritti, Ilaria, Wan, Jinkai, Weeresekara, Vajira, Gujral, Taranjit S, Bardeesy, Nabeel. . DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming. In Cancer discovery, 15, 382-400. doi:10.1158/2159-8290.CD-24-0634. https://pubmed.ncbi.nlm.nih.gov/39326063/
5. Kim, Stephanie S, Kycia, Ina, Karski, Michael, Sethupathy, Praveen, Vakili, Khashayar. 2022. DNAJB1-PRKACA in HEK293T cells induces LINC00473 overexpression that depends on PKA signaling. In PloS one, 17, e0263829. doi:10.1371/journal.pone.0263829. https://pubmed.ncbi.nlm.nih.gov/35167623/
6. Zhang, Jason Z, Lu, Tsan-Wen, Stolerman, Lucas M, Mehta, Sohum, Zhang, Jin. 2020. Phase Separation of a PKA Regulatory Subunit Controls cAMP Compartmentation and Oncogenic Signaling. In Cell, 182, 1531-1544.e15. doi:10.1016/j.cell.2020.07.043. https://pubmed.ncbi.nlm.nih.gov/32846158/
7. Zhang, Mengru, Chen, Cheng, Peng, Qingyan, Ma, Yuru, Zou, Zhurong. 2023. A novel gene therapy for methamphetamine- induced cognitive disorder with a hyper-acidified fusion variant of DnaJB1. In Molecular therapy. Nucleic acids, 31, 703-716. doi:10.1016/j.omtn.2023.02.017. https://pubmed.ncbi.nlm.nih.gov/36923951/
8. Takashima, Ken, Oshiumi, Hiroyuki, Matsumoto, Misako, Seya, Tsukasa. 2017. DNAJB1/HSP40 Suppresses Melanoma Differentiation-Associated Gene 5-Mitochondrial Antiviral Signaling Protein Function in Conjunction with HSP70. In Journal of innate immunity, 10, 44-55. doi:10.1159/000480740. https://pubmed.ncbi.nlm.nih.gov/29069650/